Treatment of Pancreatic Cancer: What Can We Really Predict Today?

por Bachet, Jean-Baptiste, Marechal, Raphael, Van Laethem, Jean-Luc
Publicado 2011

Aquaporins Involvement in Pancreas Physiology and in Pancreatic Diseases

por Arsenijevic, Tatjana, Perret, Jason, Van Laethem, Jean-Luc, Delporte, Christine
Publicado 2019

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?

por Navez, Julie, Bouchart, Christelle, Lorenzo, Diane, Bali, Maria Antonietta, Closset, Jean, van Laethem, Jean-Luc
Publicado 2021

CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges

por Arsenijevic, Tatjana, Coulonval, Katia, Raspé, Eric, Demols, Anne, Roger, Pierre P., Van Laethem, Jean-Luc
Publicado 2023

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

por Bouchart, Christelle, Navez, Julie, Closset, Jean, Hendlisz, Alain, Van Gestel, Dirk, Moretti, Luigi, Van Laethem, Jean-Luc
Publicado 2020

Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind

por Arsenijevic, Tatjana, Nicolle, Remy, Bouchart, Christelle, D’Haene, Nicky, Demetter, Pieter, Puleo, Francesco, Van Laethem, Jean-Luc
Publicado 2021

An update on treatment options for pancreatic adenocarcinoma

por Lambert, Aurélien, Schwarz, Lilian, Borbath, Ivan, Henry, Aline, Van Laethem, Jean-Luc, Malka, David, Ducreux, Michel, Conroy, Thierry
Publicado 2019

The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases

por Bohlok, Ali, Lucidi, Valerio, Bouazza, Fikri, Daher, Ali, Germanova, Desislava, Van Laethem, Jean Luc, Hendlisz, Alain, Donckier, Vincent
Publicado 2020

EUS-guided placement of fiducial markers for stereotactic body radiation therapy in pancreatic cancer: feasibility, security and a new quality score

por Figueiredo, Mariana, Bouchart, Christelle, Moretti, Luigi, Mans, Laura, Engelholm, Jean-Luc, Bali, Maria-Antonietta, Van Laethem, Jean-Luc, Eisendrath, Pierre
Publicado 2021

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease: an observational prospective multicenter study

por Figueiredo Ferreira, Mariana, Garces-Duran, Rodrigo, Eisendrath, Pierre, Devière, Jacques, Deprez, Pierre, Monino, Laurent, Van Laethem, Jean-Luc, Borbath, Ivan
Publicado 2022

Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients

por Maréchal, Raphaël, De Schutter, Jef, Nagy, Nathalie, Demetter, Pieter, Lemmers, Arnaud, Devière, Jacques, Salmon, Isabelle, Tejpar, Sabine, Van Laethem, Jean-Luc
Publicado 2010

Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial

por Auclin, Edouard, André, Thierry, Taieb, Julien, Banzi, Maria, Van Laethem, Jean-Luc, Tabernero, Josep, Hickish, Tamas, de Gramont, Aimery, Vernerey, Dewi
Publicado 2019

Undifferentiated Pancreatic Carcinoma With Osteoclast-Like Giant Cells: What Do We Know So Far?

por Demetter, Pieter, Maréchal, Raphaël, Puleo, Francesco, Delhaye, Myriam, Debroux, Sébastien, Charara, Fadi, Gomez Galdon, Maria, Van Laethem, Jean-Luc, Verset, Laurine
Publicado 2021

Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients

por Laurent, Adeline, Marechal, Raphael, Farinella, Eleonora, Bouazza, Fikri, Charaf, Yassine, Gay, France, Van Laethem, Jean‐Luc, Gonsette, Kimberly, El Nakadi, Issam
Publicado 2022

Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?

por Benkhaled, Sofian, Peters, Cedric, Jullian, Nicolas, Arsenijevic, Tatjana, Navez, Julie, Van Gestel, Dirk, Moretti, Luigi, Van Laethem, Jean-Luc, Bouchart, Christelle
Publicado 2023

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic ade...

por Bouchart, Christelle, Navez, Julie, Borbath, Ivan, Geboes, Karen, Vandamme, Timon, Closset, Jean, Moretti, Luigi, Demetter, Pieter, Paesmans, Marianne, Van Laethem, Jean-Luc
Publicado 2023

Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

por Raoul, Jean-Luc, Van Laethem, Jean-Luc, Peeters, Marc, Brezault, Catherine, Husseini, Fares, Cals, Laurent, Nippgen, Johannes, Loos, Anja-Helena, Rougier, Philippe
Publicado 2009

Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases

por Jansen, Yanina J L, Verset, Gontran, Schats, Kelly, Van Dam, Pieter-Jan, Seremet, Teofila, Kockx, Mark, Van Laethem, Jean-Luc B, Neyns, Bart
Publicado 2019

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

por Heinrich, Stefan, Besselink, Marc, Moehler, Markus, van Laethem, Jean-Luc, Ducreux, Michel, Grimminger, Peter, Mittler, Jens, Lang, Hauke, Lutz, Manfred P., Lesurtel, Mickael
Publicado 2019

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation

por Manderlier, Martin, Navez, Julie, Hein, Matthieu, Engelholm, Jean-Luc, Closset, Jean, Bali, Maria Antonietta, Van Gestel, Dirk, Moretti, Luigi, Van Laethem, Jean-Luc, Bouchart, Christelle
Publicado 2022